Clearmind Medicine Inc (CMND)
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing
Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations
BIO-TECHNE DECLARES DIVIDEND
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Perrigo to Conduct Strategic Review of its Infant Formula Business
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
Fortrea Reports Third Quarter 2025 Results
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results